Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 77 Carcinoma, Non-Small-Cell Lung 64 Lung Neoplasms 31 Hodgkin Disease 13 Lymphoma 11 Neoplasm Metastasis 10 Recurrence 8 Lymphoma, Non-Hodgkin 8 Prostatic Neoplasms 7 Neoplasms 7 Adenocarcinoma of Lung 7 Uterine Cervical Neoplasms 5 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Mesothelioma, Malignant 4 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms, Male 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Burkitt Lymphoma 3 Brain Neoplasms 3 Waldenstrom Macroglobulinemia 2

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Neoplasm × Vinorelbine × Clear all

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡